abstract |
The present invention provides compounds that inhibit protein kinase CK2 activity (CK2 activity) and compositions containing such compounds. These compounds and compositions are also useful for the treatment of proliferative disorders such as cancer, and other kinase-related conditions including inflammation, pain, and certain immune disorders and have the general formula (I): . |